Elan files for more time to file annual report

Elan announced today that it intended to file a form with the US Securities and Exchange Commission to extend until July 15 the filing date for its Annual Report for fiscal 2002.

The delay in filing is the result of a current discussions among Elan and the SEC regarding the appropriate treatment for Elan's qualifying special purpose entities, Elan Pharmaceutical Investments Lt, Elan Pharmaceutical Investments II and Elan Pharmaceutical Investments III.